Sort   by:  
 Page size 
UnknownClinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion.
Not available
S-EPMC5628266 | biostudies-literature
UnknownTargeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt.
Not available
S-EPMC5833766 | biostudies-literature
UnknownHomozygous missense variants in YKT6 result in loss of function and are associated with developmental delay, with or without severe infantile liver disease and risk for hepatocellular carcinoma.
Not available
S-EPMC11335040 | biostudies-literature
UnknownSingle cell dual-omic atlas of the human developing retina.
Not available
S-EPMC11310509 | biostudies-literature
UnknownProtein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma.
Not available
S-EPMC6160356 | biostudies-literature
UnknownInterleukin 35 Delays Hindlimb Ischemia-Induced Angiogenesis Through Regulating ROS-Extracellular Matrix but Spares Later Regenerative Angiogenesis.
Not available
S-EPMC7591706 | biostudies-literature
UnknownDeep-learning-enabled brain hemodynamic mapping using resting-state fMRI.
Not available
S-EPMC10284915 | biostudies-literature
UnknownPhase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies.
Not available
S-EPMC11879867 | biostudies-literature
UnknownDiverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.
Not available
S-EPMC6042123 | biostudies-literature
UnknownTwenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors.
Not available
S-EPMC6880770 | biostudies-literature
Sort   by:  
 Page size